Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» antitrust
antitrust
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
Flag link:
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Gilead Sciences
Teva Pharmaceutical
legal
HIV
antitrust
Flag link:
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Merck
Glenmark
Zetia
pay-for-delay
antitrust
legal
Flag link:
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Flag link:
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Viatris maintains legal winning streak with yet another EpiPen antitrust victory
Fierce Pharma
Viatris
EpiPen
Mylan
legal
antitrust
Flag link:
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest
Endpoints
JNJ
legal
Remicade
antitrust
biosimilars
Flag link:
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Flag link:
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Amarin
Hikma
legal
antitrust
generics
Vascepa
Flag link:
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table
Fierce Pharma
Gilead Sciences
legal
HIV
antitrust
Teva Pharmaceutical
JNJ
Flag link:
Novartis, Roche avoid $475M antitrust fine in French appeals court
Novartis, Roche avoid $475M antitrust fine in French appeals court
Fierce Pharma
Novartis
Roche
antitrust
Lucentis
Flag link:
Illumina Could Face Hefty Fine Over Grail Acquisition
Illumina Could Face Hefty Fine Over Grail Acquisition
Medical Devices and Diagnostics Industry
Illumina
Grail
M&A
antitrust
Europe
diagnostics
Medtech
Flag link:
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Novartis
generics
antitrust
legal
Exforge
hypertension
Flag link:
Is CVS' Acquisition of Signify in Danger of Falling Through?
Is CVS' Acquisition of Signify in Danger of Falling Through?
Motley Fool
CVS
Signify Health
M&A
antitrust
Flag link:
Illumina defeats F.T.C. in major antitrust case
Illumina defeats F.T.C. in major antitrust case
NY Times, NY
Illumina
FTC
Grail
M&A
antitrust
Flag link:
After delay, CSL's $11.7B deal for Vifor poised to close next week
After delay, CSL's $11.7B deal for Vifor poised to close next week
Fierce Pharma
M&A
CSL
Vifor
antitrust
Flag link:
Can Illumina Hold on to Grail?
Can Illumina Hold on to Grail?
Medical Devices and Diagnostics Industry
Illumina
Grail
M&A
Europe
antitrust
Flag link:
Pages
1
2
3
4
5
6
next ›
last »